Extension study of participants from the trial of early aggressive therapy in juvenile idiopathic arthritis

Journal of Rheumatology

Volumn 41, Issue 12, 2014, Pages 2459-2465

  Wallace, Carol A ^a   Ringold, Sarah ^a   Bohnsack, John ^b   Spalding, Steven J ^c   Brunner, Hermine I ^d   Milojevic, Diana ^e   Schanberg, Laura E ^f   Higgins, Gloria C ^g   O'Neil, Kathleen M ^h,i   Gottlieb, Beth S ^j   Hsu, Joyce ^k   Punaro, Marilynn G ^l   Kimura, Yukiko ^m   Hendrickson, Audrey ^a  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g OHIO STATE UNIVERSITY   (United States)

^h UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

ⁱ RILEY HOSPITAL FOR CHILDREN   (United States)

^j Northwell Health   (United States)

^k STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

^m HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

Clinical inactive disease; Early aggressive therapy; Juvenile idiopathic arthritis

Indexed keywords

ETANERCEPT; METHOTREXATE; PLACEBO; PREDNISOLONE; IMMUNOGLOBULIN G; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; EAR INFECTION; EARLY INTERVENTION; ERYTHROCYTE SEDIMENTATION RATE; FOLLOW UP; FUNCTIONAL STATUS; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MORNING STIFFNESS; PATIENT SAFETY; PHARYNGITIS; RANDOMIZED CONTROLLED TRIAL; RASH; REMISSION; SINUSITIS; TREATMENT DURATION; TREATMENT OUTCOME; WELLBEING; ARTHRITIS, JUVENILE; BLOOD; DISABILITY; DRUG COMBINATION; LONGITUDINAL STUDY; PROSPECTIVE STUDY; QUESTIONNAIRE; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

ARTHRITIS, JUVENILE; BLOOD SEDIMENTATION; CHILD; DISABILITY EVALUATION; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; LONGITUDINAL STUDIES; METHOTREXATE; PREDNISOLONE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RECEPTORS, TUMOR NECROSIS FACTOR; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84915780437     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.140347     Document Type: Article

References (16)

1. Lovell DJ, Ruperto N, Goodman S, Reiff A, Jung L, Jarosova K, et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. N Engl J Med 2008;359:810-20.
2. Lovell DJ, Reiff A, Ilowite NT, Wallace CA, Chon Y, Lin SL, et al. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum 2008;58:1496-504.
3. Ruperto N, Lovell DJ, Quartier P, Paz E, Rubio-Perez N, Silva CA, et al. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet 2008;372:383-91.
4. Bertilsson L, Andersson-Gare B, Fasth A, Forsblad-d'Elia H. A 5-year prospective population-based study of juvenile chronic arthritis: onset, disease process, and outcome. Scand J Rheumatol 2012;41:379-82.
5. Anink J, Dolman KM, van den Berg JM, van Veenendaal M, Kuijpers TW, van Rossum MAJ. Two-year outcome of juvenile idiopathic arthritis in current daily practice; what can we tell our patients? Clin Exp Rheumatol 2012;30:972-8.
6. Vidqvist K, Malin M, Varjolahti-Lehtinen T, Korpela MM. Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies. Rheumatology 2013;52:1999-2003.
7. Solari N, Palmisani E, Consolaro A, Pistorio A, Viola S, Buoncompagni A, et al. Factors associated with achievement of inactive disease in children with juvenile idiopathic arthritis treated with etanercept. J Rheumatol 2013;40:192-200.
8. Foell D, Wulffraat N, Wedderburn LR, Wittkowski H, Frosch M, Gerss J, et al. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission. JAMA 2010;303:1266-73.
9. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
10. Wallace CA, Huang B, Bandeira M, Ravelli A, Giannini EH. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum 2005;52:3554-62.
11. Ringold S, Seidel KD, Koepsell TD, Wallace CA. Inactive disease in polyarticular juvenile idiopathic arthritis: current patterns and associations. Rheumatology 2009;48:972-7.
12. Iglesias E, Torrente-Segarra V, Bou R, Ricart S, González MI, Sánchez J, et al. Non-systemic juvenile idiopathic arthritis outcome after reaching clinical remission with anti-TNF-α therapy: a clinical practice observational study of patients who discontinued treatment. Rheumatol Int 2013 Oct 26 (E-pub ahead of print).
13. Wallace CA, Giannini EH, Spalding S, Hashkes P, O'Neil K, Zeft A, et al. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum 2012;64:2012-21.
14. Wallace CA, Giannini EH, Bin H, Lukasz I, Ruperto N. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res 2011;63:929-36.
15. Emery P, Breedveld F, van der Heijde D, Ferraccioli G, Dougados M, Robertson D, et al. Two-year clinical and radiographic results with combination etanercept-methotrexate therapy versus monotherapy in early rheumatoid arthritis. Arthritis Rheum 2010;62:674-82.
16. Vermeer M, Kuper HH, Moens HJ, Drossaers-Bakker KW, van der Bijl AW, van Riel PL, et al. Sustained beneficial effects of a protocolized treat-to-target strategy in very early rheumatoid arthritis: three-year results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort. Arthritis Care Res 2013;65:1219-26.